Moderators: pumper_stumper , ernie44 , IPwatcher
Search This Board: 
Created: 04/18/2005 11:51:03 AM - Followers: 398 - Board type: Free - Posts Today: 0

 

     $DECN       
https://www.otcmarkets.com/stock/DECN/profile

                                                          

On December 18, 2020, the SEC and US Dept of Justice, announced actions against DECN due to alledged false claims about the supposed Covid-19 test being developed.

https://www.sec.gov/litigation/complaints/2020/comp-pr2020-327.pdf

On April 23, 2020, the SEC announced an action against DECN, suspending trading in the company's stock for two weeks.  There is currently a SEC court case ongoing where the SEC has identified the many reasons for the suspension.

https://www.otcmarkets.com/stock/DECN/news/SEC-Suspension-of-Trading?id=260085


Motion for Alternative Victim Notification Granted!

MINUTE ORDER granting the Government's 88 Motion for Victim Rights. The Government may provide notice to potential crime victims in this case through publication on a website maintained by the Department of Justice as an alternative to providing individualized notice. SO ORDERED. Signed by Judge Trevor N. McFadden on 3/17/2022.

ALTERNATIVE VICTIM NOTIFICATION PROCEDURES

The United States, through undersigned counsel, respectfully moves for authorization to use alternative victim notification procedures— namely, publication on a Department of Justice website—because the large number of potential crime victims in this case makes it impracticable to notify them on an individualized basis.

The website would provide a summary of the case, information regarding the case’s status, and other significant case-related documents, such as the charging documents. The website also would contain an e-mail address
and telephone number for a Victim Assistance Line through which individual potential crime victims could contact the Department of Justice with questions regarding the case.

https://www.justice.gov/criminal-vns/case/decision-diagnostics


 

DECN Earnings History

2021 Q1-Q3 - $1,374,707
  2020 - $
29,668,622-
2019 - $
3,132,295-
2018 - $2,240,220-
2017 - $2,991,404-
2016 - $2,967,357-
2015 - $2,771,345-
2014 - $1,841,010-

Total - $46,986,960-



                                     
Decision Diagnostics Corp. is a nationwide prescription and non-prescription diagnostics and home testing products distributor. We market our GenUltimate, GenSure, PetSure (test strips for dogs and cats) and GenChoice (in FDA 510(k) review), our panacea GenUltimate TBG glucose test strips and meter (in 3rd party testing), our GenPrecis test strips and meter (for private label sale), and our GenUltimate 4Pets glucose test strips and meter for the diabetic testing of dogs, cats and horses. We are also FDA approved and have complete R&D and manufacturing facilities in South Korea. We made the the first alternative glucose testing strips sold to the market in this decade and the first alternative test strip products sold into the market since early 2008.

                                                                                             
                                                                        



                                      

                                                                                                
               

Keith Berman, CEO of DECN commented, "GenViro for the Coronavirus (covid19) began as an outgrowth of our GenUltimate TBG product line. What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.

https://www.frontiersin.org/articles/10.3389/fmicb.2015.00940/full

While infectious disease testing and management has not previously been a part of our business model, we seized on this "do good" opportunity because our "Gen" line of products are and have been manufactured since 2016 in what is ground zero for Coronavirus (covid19) in Daegu, Korea. The company will have available samples of the blood of those previously infected available for testing as the company quickly converts its GenUltimate TBG methods and Precise meter, into a precise infectious disease testing device for the screening for Coronavirus."

                                                    



Read Recent Press Releases » 

Review Recent Financial Reports »

Visit PharmaTech Solutions, Inc. »

                                 

 


Mod Cash4 Updated Ibox 3/11/2020

NEWS
https://www.otcmarkets.com/stock/DECN/news


 

GenViro! 12-Month Forecast

Number of Months

1

2

3

4

5

6

7

8

9

10

11

12

SUM

Year 1

Apr-20

May-20

Jun-20

Jul-20

Aug-20

Sep-20

Oct-20

Nov-20

Dec-20

Jan-21

Feb-21

Mar-21

 
                           

New Facility Customers

0

0

0

0

0

5000

5000

5000

5000

5000

5000

5000

 

Retained Facilities

0

0

0

0

0

0

5000

10000

15000

20000

25000

30000

 

Total Facility Customers

0

0

0

0

0

5000

10000

15000

20000

25000

30000

35000

35,000

Kits Consumed

0

0

0

0

0

15,000,000

30,000,000

45,000,000

60,000,000

75,000,000

90,000,000

105,000,000

420,000,000

We are not resting our laurels with our GenViro development. Later product entries will be test methods for Polio, Ebola (Marburg), Bird Flu, and SARS. The cost of our test kits will be sold in a price range of $4.95 to $7.95 per use. The Coronavirus kit will be sold for $6.95. Each kit sold will carry enough diagnostic for two tests, a primary test, and a test in reserve in case of human error in administrating the primary test. We plan to provide our diagnostics initially for use at hospitals, doctors' offices, and clinics. Once production ramps up, we will offer testing kits and meters to patients for testing at-home.

Mr. Berman concluded, "As you might imagine with a product announcement of such importance, we have been contacted by a number of potential partners for our kit, as well as companies who were not chosen last time to proceed past the proposition stage. The company's first choice for partnering will be a company that made "the cut" last time for our GenUltimate! TBG product. We will discuss partnering potential in a coming release. For the moment, the company is content calling on big box and long term care chains through its existing distributors and agents."

DECN also markets its PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leding Zoetis Alpha Trak meter system as well as the GenUltimate! 4Pets Test strip and Avantage! meter. The company has also just introduced its GenExpidient! Universal Translator for bio-sensor devices of different manufacture. A GenExpidient! device will be included in every Covid19 kit. Having such a device will lower the incidence of cleaning and disinfecting the GenViro! meter.

ABOUT DECISION DIAGNOSTICS CORP

Decision  

Forward-Looking Statements:

This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of March 11 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.
Keith Berman (805) 446-2973

info@decisiondiagnostics.co
www.genultimate.com
www.genultimatetbg.com
www.petsureteststrips.com
www.pharmatechdirect.com

SOURCE: Decision Diagnostics Corp.



View source version on accesswire.com:
https://www.accesswire.com/579985/DECN-Provides-First-Looks-At-Its-GenViroTM-Corona-Virus-Screening-Kit-First-Year-Product-Forecast-of-420-Million-Kits-with-Sales-Beginning-Late-3Q-2020


 

SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device
FOR IMMEDIATE RELEASE

2020-327

Washington D.C., Dec. 18, 2020 —
The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020.

The SEC's complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and misleading statements about the existence of Decision Diagnostics' Covid-19 device and progress towards FDA emergency use authorization. As alleged, at the time of these claims, Decision Diagnostics lacked a proven method for detecting the virus and had no physical testing device. Further, its advisors had warned that the testing kit they were trying to manufacture would not work as Decision Diagnostics had described. The complaint also alleges that the statements created the misleading impression that the test was soon to be introduced to the market and led to surges in the price and trading volume of Decision Diagnostics' stock.

"During this unprecedented time, when the need for truthful disclosures concerning Covid-19 tests is of vital importance, Decision Diagnostics and its CEO allegedly misled investors by claiming to have made a working test device when all they had was an idea that had not materialized into a product," said Stephanie Avakian, Director of the Division of Enforcement. "With the onset of the global pandemic, we quickly pivoted to identify potential areas of fraud. This case is another example of how the Commission will hold accountable those who exploit the pandemic to harm investors."

"In our complaint, we allege that Decision Diagnostics and Berman repeatedly made baseless representations to the investing public about market-moving events like progress in obtaining FDA approval and having breakthrough technology," said Anita B. Bandy, Associate Director of the Division of Enforcement. "Today's filing is a credit to the dedicated SEC staff, who continued to investigate after the trading suspension and quickly uncovered the alleged fraud."

The complaint, filed in the U.S. District Court for the Southern District of New York, charges Decision Diagnostics and Berman with violating antifraud provisions of the securities laws. The SEC is seeking a court order permanently enjoining both Decision Diagnostics and Berman from directly or indirectly violating those provisions and ordering them to pay civil penalties.

The Department of Justice's Market Integrity and Major Frauds Unit announced today that parallel criminal charges against Berman were also filed in the U.S. District Court for the District of Columbia.

The SEC's investigation, which is continuing, has been conducted by Ernesto Amparo, Carlisle Perkins and Lesley Atkins and supervised by Jeff Leasure and Ms. Bandy with invaluable assistance by Margaret A. Cain of the Office of Market Intelligence and Hane L. Kim of the Microcap Fraud Task Force, both members of the SEC's Coronavirus Steering Committee. The litigation will be handled by James Carlson, David Misler and supervised by Tom Bednar. The SEC appreciates the assistance of the Financial Industry Regulatory Authority.

https://www.sec.gov/news/press-release/2020-327

https://www.sec.gov/litigation/09/complaints/2020/comp-pr2020-327.pdf

 
DECN SECURITY DETAILS

Share Structure

 
Authorized Shares
494,995,000
 
Outstanding Shares

02/14/22 - 380,486,143
11/12/21 - 358,500,583
09/30/21 - 357,780,503
12/17/20 - Berman arrested by FBI

12/11/20 - 349,741,793
11/06/20 - 332,025,278
10/09/20 - 325,752,685
09/11/20 -  313,434,787
08/07/20 - 305,063,608
07/10/20 - 302,663,608
05/15/20 - 267,213,123
04/03/20 - 212,000,000
03/31/20 - 199,792,833
03/06/20 - 159,999,161
12/31/19 - 156,679,161
12/31/18 - 134,551,840
12/31/17 - 110,241,640
12/31/16 - 84,639,908 

 
 
Restricted

07/10/2020 - 5,969,436
10/09/2020 - 9,983,981
12/10/2021 - 18,742,771
 
Unrestricted
12/10/2021 - 339,757,812
02/15/2022 - 361,025,480
 

 

 
 
 
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#96655
Motion for Alternative Victim Notification Granted! pumper_stumper 03/18/2022 12:46:31 PM
#94285
LINKS TO COURT DOCUMENTS IN BERMAN/DECN SECURITIES FRAUD PROCEEDINGS: IPwatcher 01/17/2021 01:53:26 AM
#96762
alert------- move to CANADA ...................... ernie44 08/18/2022 10:31:04 AM
#96761
Hearing on the default judgement in the Sanchez IPwatcher 08/17/2022 07:13:13 PM
#96760
Lol, you sure can buy a lot of Johnny_C 08/15/2022 09:25:23 AM
#96759
I think he thought he was going to Johnny_C 08/15/2022 09:22:52 AM
#96758
Well, unless they want certificates to wallpaper their IPwatcher 08/14/2022 05:51:15 PM
#96757
Fear-mongering works. IPwatcher 08/14/2022 05:36:30 PM
#96756
Ditto! He was really fired up for pumper_stumper 08/11/2022 01:22:40 PM
#96755
LOL , but they might want to do Johnny_C 08/11/2022 12:41:27 PM
#96754
"I dunno. Perhaps late this week or perhaps Johnny_C 08/11/2022 12:38:02 PM
#96753
Fear-mongering works. ernie44 08/11/2022 11:06:50 AM
#96752
25 cent buy today IPwatcher 08/10/2022 04:49:04 PM
#96751
25 cent buy today! "Someone must pumper_stumper 08/10/2022 04:24:15 PM
#96750
DECN NO BID--NO ASK ernie44 08/05/2022 08:22:02 PM
#96749
They are probably going to be disappointed that IPwatcher 08/03/2022 01:25:10 PM
#96748
That's great, someone took the site name! pumper_stumper 08/03/2022 09:04:24 AM
#96747
Still, there's always the generic test strip business IPwatcher 08/03/2022 08:43:20 AM
#96746
A few classic Berman posts. pumper_stumper 07/31/2022 08:47:50 AM
#96744
I wouldn't be surprised if the case is continued... Johnny_C 07/27/2022 06:59:43 AM
#96743
Good Find! Johnny_C 07/27/2022 06:56:17 AM
#96741
Case still on track for December. pumper_stumper 07/26/2022 02:46:00 PM
#96740
remember when we could call ''Man-from-GLAD '' ernie44 07/21/2022 09:57:11 AM
#96739
LOL ........who do we call now ??? IPwatcher 07/18/2022 09:05:26 PM
#96738
LOL ........who do we call now ??? ernie44 07/17/2022 10:44:51 AM
#96737
Does anyone have access to the California class Johnny_C 07/17/2022 06:40:44 AM
#96736
I wouldn't be surprised if it is delayed again. Johnny_C 07/17/2022 06:38:51 AM
#96735
I had almost completely forgotten about this doosh IPwatcher 07/15/2022 03:41:54 PM
#96734
I came across an article stating that corporate Jelly Bean 07/15/2022 06:58:07 AM
#96733
this one has had the bun ernie44 07/03/2022 02:19:32 PM
#96732
One share traded today at 0.0003. (Volume = pumper_stumper 06/24/2022 08:07:53 PM
#96731
Isn't MonkeyPox spread by sex, maybe Bozo Berman Johnny_C 06/01/2022 10:05:17 AM
#96730
You're right, and, all those tests with animals pumper_stumper 05/31/2022 02:41:20 PM
#96729
Why stop at MonkeyPox.. If you remember this Johnny_C 05/31/2022 02:31:26 PM
#96728
Gen-Viro MonkeyPox Test? pumper_stumper 05/28/2022 05:03:32 PM
#96727
I guess he doesn’t know that clinical trials Johnny_C 05/19/2022 12:27:10 PM
#96726
Omg, is there anything in Bozo Berman’s press Johnny_C 05/19/2022 12:25:40 PM
#96725
My money says they took away a "few" I ll be back 05/19/2022 11:01:59 AM
#96724
Interesting! We will NEVER find out as the snake IPwatcher 05/19/2022 10:53:00 AM
#96723
Interesting! We will NEVER find out as the snake I ll be back 05/19/2022 09:38:51 AM
#96722
LICGO litigation settled our of court. IPwatcher 05/19/2022 05:01:59 AM
#96721
true enough----- things remain LQQKING ''BAAAAAAAD'' ernie44 05/18/2022 09:36:49 AM
#96720
It seems like a pretty easy clinical IPwatcher 05/17/2022 06:20:49 PM
#96719
Basically, Berman would have to try and show IPwatcher 05/17/2022 06:16:53 PM
#96718
Maybe they can hire the losers to be PlutoniumImplosion07 05/17/2022 03:33:49 PM
#96717
No offense but a lot of this stuff PlutoniumImplosion07 05/17/2022 03:30:58 PM
#96716
During hard times and a looming recession---people turn ernie44 05/16/2022 05:07:53 PM
#96715
If this actually goes to trial, Berman has IPwatcher 05/16/2022 01:26:52 PM
#96714
BERMAN can't be that stupid ----he will just ernie44 05/15/2022 06:56:46 PM
#96713
If this actually goes to trial, Berman has PlutoniumImplosion07 05/15/2022 03:42:59 PM
#96712
That sounds like a lot of fun. The PlutoniumImplosion07 05/14/2022 03:12:35 PM
#96710
You should join us in Washington for the Johnny_C 05/12/2022 10:00:41 PM
Post Subject